TERM CREDIT AGREEMENT dated as of July 15, 2015 among MYLAN INC., as a Borrower MYLAN N.V., as a Guarantor and The other Borrowers and Guarantors party hereto and PNC BANK, NATIONAL ASSOCIATION, as Administrative Agent THE BANK OF TOKYO- MITSUBISHI...Term Credit Agreement • October 30th, 2015 • Mylan N.V. • Pharmaceutical preparations • New York
This TERM CREDIT AGREEMENT (this “Agreement”) is dated as of July 15, 2015 among MYLAN INC., a Pennsylvania corporation (“Mylan”), MYLAN N.V., a public limited liability company (naamloze vennootschap) organized and existing under the laws of the Netherlands (the “Company”), certain Affiliates and Subsidiaries of Mylan from time to time party hereto as a Designated Borrower, Successor Borrower or Guarantor, each Lender from time to time party hereto, and PNC BANK, NATIONAL ASSOCIATION, as Administrative Agent.
AMENDMENT NO. 1 TO TERM CREDIT AGREEMENTTerm Credit Agreement • October 30th, 2015 • Mylan N.V. • Pharmaceutical preparations • New York
AMENDMENT dated as of October 28, 2015 to the Term Credit Agreement dated as of July 15, 2015 (the “Credit Agreement”), among MYLAN INC. (the “Borrower”), MYLAN N.V. (the “Company”), the other borrowers and guarantors party thereto, the Lenders party thereto from time to time (the “Lenders”) and PNC BANK, NATIONAL ASSOCIATION, as Administrative Agent (the “Agent”).
AMENDMENT NO. 2 TO REVOLVING CREDIT AGREEMENTRevolving Credit Agreement • October 30th, 2015 • Mylan N.V. • Pharmaceutical preparations • New York
AMENDMENT dated as of October 28, 2015 to the Revolving Credit Agreement dated as of December 19, 2014 (as amended by Amendment No. 1 dated as of May 1, 2015 and by the Additional Credit Extension Amendment dated as of June 19, 2015, the “Credit Agreement”), among MYLAN INC. (the “Borrower”), MYLAN N.V. (the “Company”), the other borrowers and guarantors party thereto, the Lenders and Issuing Banks party thereto from time to time (the “Lenders”) and BANK OF AMERICA, N.A., as Administrative Agent (the “Agent”).
Transition and Succession Agreement Waiver LetterSuccession Agreement • October 30th, 2015 • Mylan N.V. • Pharmaceutical preparations
Reference is made to your Transition and Succession Agreement with Mylan Inc., as such agreement has been and may be amended from time to time (the “T&S Agreement”). The T&S Agreement provides for the possibility of enhanced benefits or rights following a Change in Control (as such term is defined in the T&S Agreement) of Mylan N.V. (the “Company”). By executing this waiver letter, for good and valuable consideration (including your continued employment and continued participation in the incentive plans and programs of the Company and its subsidiaries), you acknowledge and agree that the Company’s proposed acquisition of Perrigo Company plc shall not constitute a Change in Control for any purpose of the T&S Agreement. All other provisions of the T&S Agreement, as modified by the foregoing, shall remain in full force and effect notwithstanding this waiver letter.
AMENDMENT NO. 2 TO TERM CREDIT AGREEMENTTerm Credit Agreement • October 30th, 2015 • Mylan N.V. • Pharmaceutical preparations • New York
AMENDMENT dated as of October 28, 2015 to the Term Credit Agreement dated as of December 19, 2014 (as amended by Amendment No. 1 dated as of May 1, 2015, the “Credit Agreement”), among MYLAN INC. (the “Borrower”), MYLAN N.V. (the “Company”), the other borrowers and guarantors party thereto, the Lenders party thereto from time to time (the “Lenders”) and BANK OF AMERICA, N.A., as Administrative Agent (the “Agent”).
